The following data is part of a premarket notification filed by Koios Medical, Inc. with the FDA for Koios Ds.
| Device ID | K212616 | 
| 510k Number | K212616 | 
| Device Name: | Koios DS | 
| Classification | Computer-assisted Diagnostic Software For Lesions Suspicious For Cancer | 
| Applicant | Koios Medical, Inc. 242 West 38th Street, 14th Floor New York, NY 10018 | 
| Contact | Patricia Setti-laperch | 
| Correspondent | Patricia Setti-laperch Koios Medical, Inc. 242 West 38th Street, 14th Floor New York, NY 10018 | 
| Product Code | POK | 
| CFR Regulation Number | 892.2060 [🔎] | 
| Decision | Substantially Equivalent (SESE) | 
| Type | Traditional | 
| 3rd Party Reviewed | No | 
| Combination Product | No | 
| Date Received | 2021-08-18 | 
| Decision Date | 2021-12-16 | 
| Device Identifier | submissionNumber | Supplement | 
|---|---|---|
| 00860002545714 | K212616 | 000 | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  KOIOS DS  88421199  not registered Live/Pending | KOIOS MEDICAL, INC 2019-05-08 |